Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration.

Autor: Zengin ZB; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Henderson NC; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA., Park JJ; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA., Ali A; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA., Nguyen C; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA., Hwang C; Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Health System, Detroit, MI, USA., Barata PC; Tulane Cancer Center, Tulane University, New Orleans, LA, USA., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Graham L; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Mo G; University of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USA., Kilari D; Department of Medicine, Froedtert Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA., Tripathi A; Stephenson Cancer Center, Oklahoma City, OK, USA., Labriola M; Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Rothstein S; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Garje R; Holden Comprehensive Cancer Center, Iowa City, IA, USA., Koshkin VS; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Patel VG; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Arvinas Inc, New Haven, CT, USA., Schweizer MT; University of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USA., Armstrong AJ; Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Alva A; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA., Dorff T; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. tdorff@coh.org.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Feb 22. Date of Electronic Publication: 2024 Feb 22.

Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer.

Autor: Hwang C; Henry Ford Health, Detroit, Michigan., Henderson NC; University of Michigan, Ann Arbor, Michigan., Chu SC; University of Michigan, Ann Arbor, Michigan., Holland B; Wayne State University School of Medicine, Detroit, Michigan., Cackowski FC; Wayne State University School of Medicine, Detroit, Michigan.; Karmanos Cancer Institute, Detroit, Michigan., Pilling A; Henry Ford Health, Detroit, Michigan., Jang A; Tulane University, New Orleans, Louisiana., Rothstein S; Wayne State University School of Medicine, Detroit, Michigan.; Karmanos Cancer Institute, Detroit, Michigan., Labriola M; Division of Medical Oncology, Department of Medicine, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, North Carolina., Park JJ; University of Michigan, Ann Arbor, Michigan., Ghose A; University of Michigan, Ann Arbor, Michigan., Bilen MA; Emory University, Atlanta, Georgia., Mustafa S; Emory University, Atlanta, Georgia., Kilari D; Medical College of Wisconsin, Milwaukee, Wisconsin., Pierro MJ; Medical College of Wisconsin, Milwaukee, Wisconsin., Thapa B; Medical College of Wisconsin, Milwaukee, Wisconsin., Tripathi A; University of Oklahoma, Oklahoma City, Oklahoma., Garje R; University of Iowa, Iowa City, Iowa., Ravindra A; University of Iowa, Iowa City, Iowa., Koshkin VS; University of California San Francisco, San Francisco, California., Hernandez E; University of California San Francisco, San Francisco, California., Schweizer MT; University of Washington, Seattle, Washington., Armstrong AJ; Division of Medical Oncology, Department of Medicine, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, North Carolina., McKay RR; University of California San Diego, La Jolla, California., Dorff TB; City of Hope, Duarte, California., Alva AS; University of Michigan, Ann Arbor, Michigan., Barata PC; Tulane University, New Orleans, Louisiana.; University Hospitals Seidman Cancer Center, Cleveland, Ohio.

Publikováno v: JAMA network open [JAMA Netw Open] 2023 Sep 05; Vol. 6 (9), pp. e2334208. Date of Electronic Publication: 2023 Sep 05.

Molecular Genetics of Self-incompatibility in Brassica napus

Autor: BRUGIÈRE, N., CUI, Y., BI, Y., ARNOLDO, M., JACKMAN, L., ROTHSTEIN, S. J.

Publikováno v: Annals of Botany, 2000 Mar 01. 85, 133-139.

Externí odkaz: https://www.jstor.org/stable/42770678

Potential of Hermetia illucens larvae meal as protein source in broiler diets.

Autor: Rothstein, S.

Publikováno v: Lohmann Information; 2021, Issue 2, p5-18, 14p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.